Frontiers in Cellular Neuroscience, 2022 · DOI: 10.3389/fncel.2022.898546 · Published: May 27, 2022
This editorial discusses recent preclinical research advances in CNS repair, regeneration, and neuroplasticity, focusing on new molecular and cellular targets and effective therapeutic strategies. The Research Topic includes studies targeting multiple molecular and cellular components using several model systems, including traumatic brain injury (TBI), spinal cord injury (SCI), optic nerve crush (ONC), neurodegeneration, and in vitro cell cultures. Many articles focused on enhancing viability of neural cells and regeneration, reconnection, and plasticity of injured CNS neurons by targeting diverse CNS pathophysiology, including inflammatory cascades and regeneration failure of axotomized CNS axons.
Identification of druggable targets for secondary brain injuries can lead to new pharmaceutical interventions.
Non-invasive respiratory treatments show promise for enhancing neuroplasticity and recovery after cervical SCI.
Further validation in primates and humans is needed to confirm the effectiveness of identified strategies for CNS repair.